Experience with sonidegib in patients with advanced basal cell carcinoma: case reports

Experience with sonidegib in patients with advanced basal cell carcinoma: case reports

Sonidegib is a Hedgehog signalling pathway inhibitor approved for use in patients with advanced basal cell carcinoma (BCC) not eligible for surgery or radiotherapy. This report describes clinical experience with sonidegib in two patients with locally advanced BCC (one with a tumour adjacent to the r...

Full description

Bibliographic Details
Main Authors:	Susana Puig, Carlos Serra-Guillén, Gemma Pérez-Pastor, Álvaro Martínez-Domenech, Ricardo Fernández-de-Misa Cabrera
Format:	Article
Language:	English
Published:	BioExcel Publishing Ltd 2022-05-01
Series:	Drugs in Context
Subjects:	case reports gorlin syndrome locally advanced basal cell carcinoma sonidegib vismodegib
Online Access:	https://www.drugsincontext.com/experience-with-sonidegib-in-patients-with-advanced-basal-cell-carcinoma-case-reports

Similar Items

Benefit–risk assessment of sonidegib and vismodegib in the treatment of locally advanced basal cell carcinoma
by: Antonio J García Ruiz, et al.
Published: (2022-07-01)

Sustained Suppression of Gorlin Syndrome-Associated Basal Cell Carcinomas with Vismodegib or Sonidegib: A Case Series
by: Raquel Wescott, et al.
Published: (2023-10-01)

The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area
by: Alessia Villani, et al.
Published: (2023-07-01)

Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma
by: Olivia M. Chen, et al.
Published: (2022-07-01)

Vismodegib y sonidegib en el carcinoma de células basales localmente avanzado y metastásico: actualización acerca de los inhibidores de la vía de Hedgehog
by: J. Kurnia Wijaya, et al.
Published: (2022-05-01)

Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial
by: Lear JT, et al.
Published: (2020-02-01)

Sonidegib for the Treatment of Advanced Basal Cell Carcinoma
by: Gabriella Brancaccio, et al.
Published: (2020-10-01)

Multicenter Retrospective Andalusian Study of the Use of Sonidegib for the Treatment of Local Advanced Basal Cell Carcinoma in Real Clinical Practice
by: Ricardo Ruiz-Villaverde, et al.
Published: (2023-08-01)

Sonidegib in the Treatment of Locally Advanced Basal Cell Carcinoma: A Retrospective Study
by: Florian Herms, et al.
Published: (2022-06-01)

Basal cell cancer treatment. Therapeutic experience with vismodegib therapy
by: N. N. Petenko, et al.
Published: (2018-07-01)

Clinical Clearance Following Improvement of Histologic Subtype of Basal Cell Carcinoma with Sonidegib
by: Liang Joo Leow, et al.
Published: (2022-11-01)

Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma
by: Alessia Villani, et al.
Published: (2020-04-01)

Real-Life Experience with Sonidegib for Locally Advanced Basosquamous Carcinoma: A Case Series
by: Enrico Bocchino, et al.
Published: (2024-01-01)

Hedgehog Pathway Inhibitors and Their Utility in Basal Cell Carcinoma: A Comprehensive Review of Current Evidence
by: Evelyn Yu-Xin Tay, et al.
Published: (2018-12-01)

Sonidegib in Locally Advanced Basal Cell Carcinoma: A Monocentric Retrospective Experience and a Review of Published Real-Life Data
by: Gianluca Nazzaro, et al.
Published: (2023-07-01)

Gorlin Syndrome: Sequential Digital Dermoscopy of Palpebral Basal Cell Carcinomas in a Patient Treated With Vismodegib
by: Luis Mena-Vergara, et al.
Published: (2022-02-01)

[Translated article] Vismodegib and Sonidegib in Locally Advanced and Metastatic Basal Cell Carcinoma: Update on Hedgehog Pathway Inhibitors
by: J. Kurnia Wijaya, et al.
Published: (2022-05-01)

Sonidegib en el tratamiento del carcinoma basocelular localmente avanzado
by: O. Sanmartín, et al.
Published: (2021-04-01)

Treatment of Advanced Basal Cell Carcinoma with Hedgehog Pathway Inhibitors: A Multidisciplinary Expert Meeting
by: Vincenzo De Giorgi, et al.
Published: (2021-11-01)

Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis
by: Yuchen Li, et al.
Published: (2019-07-01)

A Vismodegib Experience in Elderly Patients with Basal Cell Carcinoma: Case Reports and Review of the Literature
by: Anna Passarelli, et al.
Published: (2020-11-01)

Topical Delivery of Hedgehog Inhibitors: Current Status and Perspectives
by: Kristian Kåber Pedersen, et al.
Published: (2022-11-01)

Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study)
by: Nicolas Bertrand, MD, et al.
Published: (2021-05-01)

Targeted Delivery of 5-Fluorouracil and Sonidegib via Surface-Modified ZIF-8 MOFs for Effective Basal Cell Carcinoma Therapy
by: Bharath Singh Padya, et al.
Published: (2023-11-01)

Vismodegib dose reduction effective when combined with itraconazole for the treatment of advanced basal cell carcinoma
by: Jaeyoung Yoon, MD, PhD
Published: (2021-01-01)

Evaluation of Hedgehog Pathway Inhibition on Nevoid Basal Cell Carcinoma Syndrome Fibroblasts and Basal Cell Carcinoma-Associated Fibroblasts: Are Vismodegib and Sonidegib Useful to Target Cancer-Prone Fibroblasts?
by: Laura Eibenschutz, et al.
Published: (2021-11-01)

Assessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib: results from a preplanned sensitivity analysis
by: Ralf Gutzmer, et al.
Published: (2021-11-01)

Periocular basal cell carcinoma - clinical perspectives
by: Alena Furdova, et al.
Published: (2020-04-01)

Basal cell nevus syndrome
by: Elizabeth L. Hall, et al.
Published: (2022-06-01)

Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome
by: Glen J. Weiss, et al.
Published: (2011-12-01)

A case of metastatic basal cell carcinoma treated with carboplatin and paclitaxel
by: Chryssoula Papageorgiou, et al.
Published: (2023-01-01)

Granulation tissue masquerading as basal cell carcinoma after treatment with vismodegib
by: Jayson Miedema, MD, et al.
Published: (2018-01-01)

A Multidisciplinary approach to metastatic giant basal cell carcinoma—A case report
by: Leo E.T. Lehto, et al.
Published: (2024-06-01)

Metastatic basal cell carcinoma to the bone: a case of bone metastatis in unfrequent sites
by: Olga Nigro, et al.
Published: (2022-07-01)

Complete pathologic clearance with vismodegib in advanced basal cell carcinoma of the scalp with cranial invasion
by: Joseph Dodson, et al.
Published: (2022-12-01)

Transformation of facial basal cell carcinoma to squamous cell carcinoma following vismodegib
by: Dustin A. Silverman, et al.
Published: (2021-09-01)

Recent Advances in the Clinical Targeting of Hedgehog/GLI Signaling in Cancer
by: Hao Xie, et al.
Published: (2019-04-01)

Different Response of Ptch Mutant and Ptch Wildtype Rhabdomyosarcoma Toward SMO and PI3K Inhibitors
by: Natalie Geyer, et al.
Published: (2018-09-01)

Metastatic same-site squamous cell carcinoma arising during vismodegib therapy for basal cell carcinoma
by: Raymond Zhao, BS, et al.
Published: (2022-10-01)

Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity
by: Massimiliano Scalvenzi, et al.
Published: (2020-04-01)